Positive mid-stage results for Medicago and GSK’s plant-derived COVID-19 vaccine
Plant-derived vaccine candidate showed promising antibody responses against COVID-19 in Phase II study
Read More
Tag: Medicago
GSK, Medicago launch late-stage trial of plant-derived COVID-19 vaccine
Vaccine candidate has previously been granted FDA fast track designation
Read More
GSK links with Medicago to develop novel COVID-19 vaccine
Phase I clinical testing scheduled to begin mid-July
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
